Angus W Thomson is a prominent inventor based in Pittsburgh, PA (US), known for his significant contributions to the field of transplant immunology. With a total of 7 patents, Thomson has focused on advancing the understanding of allograft rejection and improving immunosuppressive therapies for organ transplant recipients.

Latest Patents

Thomson's latest patents include groundbreaking work on the use of eomesodermin to determine the risk of allograft rejection. His research highlights the role of pre-existing alloreactive memory T cells as a major barrier to achieving allograft tolerance in organ transplant recipients. The patents describe how Eomesodermin (Eomes) expression in memory T cells can be utilized to assess the risk of allograft rejection in subjects. Furthermore, the patents outline the potential for using Eomes expression in memory T cells of transplant recipients to modify immunosuppressive therapy, thereby enhancing patient outcomes.

Career Highlights

Thomson's career is marked by his dedication to improving transplant success rates through innovative research. His work has not only contributed to the scientific community but has also had a profound impact on clinical practices in organ transplantation.

Collaborations

Thomson has collaborated with notable figures in the field, including Anthony J Demetris and Thomas E Starzl. These partnerships have fostered a collaborative environment that promotes the advancement of transplant immunology.

Conclusion

Angus W Thomson's innovative research and patents in the field of transplant immunology demonstrate his commitment to improving the lives of organ transplant recipients. His work continues to pave the way for advancements in understanding and managing allograft rejection.